share_log

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $28 Price Target

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $28 Price Target

HC Wainwright & Co.重申买入Olema Pharmicals,维持28美元的目标价
Benzinga ·  2023/10/11 07:46

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $28 price target.

HC Wainwright&Co.分析师Emily Bodnar重申Olema制药(纳斯达克:OLMA)的买入,并维持28美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发